Table 1: Pancreatic Cancer – Pipeline Products by Stage of Development 15
Table 2: Pancreatic Cancer – Pipeline Products by Territory 16
Table 3: Pancreatic Cancer – Pipeline Products by Regulatory Path 17
Table 4: Pancreatic Cancer – Pipeline Products by Estimated Approval Date 18
Table 5: Pancreatic Cancer – Ongoing Clinical Trials 19
Table 6: Pancreatic Cancer Companies – Pipeline Products by Stage of Development 20
Table 7: Pancreatic Cancer – Pipeline Products by Stage of Development 24
Table 8: 2cureX AB Pipeline Products & Ongoing Clinical Trials Overview 28
Table 9: IndiTreat – PC – Product Status 28
Table 10: IndiTreat – PC – Product Description 28
Table 11: 2cureX AB – Ongoing Clinical Trials Overview 29
Table 12: IndiTreat – PC – Predictive Value of In-vitro Anti-cancer Therapy Sensitivity Testing on Tumoroids from Patients with Metastatic Pancreatic Cancer 30
Table 13: 3rd Street Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 31
Table 14: Diagnostic Test Kit – Pancreatic Ductal Adenocarcinoma – Product Status 31
Table 15: Diagnostic Test Kit – Pancreatic Ductal Adenocarcinoma – Product Description 31
Table 16: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 17: Companion Diagnostic Test – Pancreatic Cancer – Product Status 32
Table 18: Companion Diagnostic Test – Pancreatic Cancer – Product Description 32
Table 19: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
Table 20: Diagnostic Assay – Pancreatic Cancer – Product Status 33
Table 21: Diagnostic Assay – Pancreatic Cancer – Product Description 33
Table 22: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 34
Table 23: Companion Diagnostic Assay – Masitinib – Product Status 34
Table 24: Companion Diagnostic Assay – Masitinib – Product Description 34
Table 25: Diagnostic/Prognostic Assay – Pancreatic Cancer – Product Status 35
Table 26: Diagnostic/Prognostic Assay – Pancreatic Cancer – Product Description 35
Table 27: GemciTest – Product Status 35
Table 28: GemciTest – Product Description 36
Table 29: Acobiom – Ongoing Clinical Trials Overview 37
Table 30: GemciTest – Evaluation of GEMCITEST in Patients with Pancreatic Cancer and Treated by Chemotherapy (GEMCIPANC) 38
Table 31: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 39
Table 32: PancreaDix – Product Status 39
Table 33: PancreaDix – Product Description 39
Table 34: Alaunus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 35: Diagnostic Assay – Pancreatic Cancer – Product Status 40
Table 36: Diagnostic Assay – Pancreatic Cancer – Product Description 40
Table 37: Amplified Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview 41
Table 38: PanCystPro – Product Status 41
Table 39: PanCystPro – Product Description 41
Table 40: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
Table 41: Cchek – Pancreatic Cancer Confirmatory Test – Product Status 42
Table 42: Cchek – Pancreatic Cancer Confirmatory Test – Product Description 42
Table 43: Cchek – Pancreatic Cancer Recurrence Test – Product Status 43
Table 44: Cchek – Pancreatic Cancer Recurrence Test – Product Description 43
Table 45: Cchek – Pancreatic Cancer Screening Test – Product Status 43
Table 46: Cchek – Pancreatic Cancer Screening Test – Product Description 44
Table 47: Cchek – Pancreatic Cancer Treatment Monitoring Test – Product Status 44
Table 48: Cchek – Pancreatic Cancer Treatment Monitoring Test – Product Description 44
Table 49: Anixa Diagnostics Corporation – Ongoing Clinical Trials Overview 45
Table 50: Cchek – Pancreatic Cancer Screening Test – The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors 46
Table 51: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 52: API Diagnostic Test – Pancreatic Cancer – Product Status 47
Table 53: API Diagnostic Test – Pancreatic Cancer – Product Description 47
Table 54: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 55: TheraLink Assay – Pancreatic Cancer – Product Status 48
Table 56: TheraLink Assay – Pancreatic Cancer – Product Description 48
Table 57: Axim Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 58: Diagnostic Test – Pancreatic Cancer – Product Status 49
Table 59: Diagnostic Test – Pancreatic Cancer – Product Description 49
Table 60: Berg LLC Pipeline Products & Ongoing Clinical Trials Overview 50
Table 61: Biomarker Assay – Pancreatic Cancer – Product Status 50
Table 62: Biomarker Assay – Pancreatic Cancer – Product Description 50
Table 63: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 51
Table 64: Ex Vivo Biomarker Test – Pancreatic Cancer – Product Status 51
Table 65: Ex Vivo Biomarker Test – Pancreatic Cancer – Product Description 51
Table 66: BiomaRx Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 67: Non-Invasive Diagnostic Test – Pancreatic Cancer – Product Status 52
Table 68: Non-Invasive Diagnostic Test – Pancreatic Cancer – Product Description 52
Table 69: PDAC Diagnostic v2.0 – Product Status 53
Table 70: PDAC Diagnostic v2.0 – Product Description 53
Table 71: PDAC FFPE Biopsy Test v1.0 – Product Status 53
Table 72: PDAC FFPE Biopsy Test v1.0 – Product Description 54
Table 73: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview 55
Table 74: MBDAA Pancreatic Cancer Test – Product Status 55
Table 75: MBDAA Pancreatic Cancer Test – Product Description 55
Table 76: Biouniversa srl Pipeline Products & Ongoing Clinical Trials Overview 56
Table 77: BAG3 ELISA Kit – Pancreatic Adenocarcinoma – Product Status 56
Table 78: BAG3 ELISA Kit – Pancreatic Adenocarcinoma – Product Description 56
Table 79: BAG3 ELISA Kit – Pancreatic Adenocarcinoma Early Diagnosis – Product Status 57
Table 80: BAG3 ELISA Kit – Pancreatic Adenocarcinoma Early Diagnosis – Product Description 57
Table 81: Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
Table 82: IHC Based Test – Pancreatic Cancer – Product Status 58
Table 83: IHC Based Test – Pancreatic Cancer – Product Description 58
Table 84: Captis Biotechnology Inc Pipeline Products & Ongoing Clinical Trials Overview 59
Table 85: Diagnostic Test – Precancerous Pancreatic Lesions – Product Status 59
Table 86: Diagnostic Test – Precancerous Pancreatic Lesions – Product Description 59
Table 87: Caris Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 88: Companion Diagnostic Assay – Pancreatic Cancer – Product Status 60
Table 89: Companion Diagnostic Assay – Pancreatic Cancer – Product Description 60
Table 90: Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Table 91: XPERT Pancreatic CA Early Detection Test – Product Status 61
Table 92: XPERT Pancreatic CA Early Detection Test – Product Description 61
Table 93: Xpert Pancreatic CA Monitor Assay – Product Status 62
Table 94: Xpert Pancreatic CA Monitor Assay – Product Description 62
Table 95: Clovis Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 96: hENT1 Companion Diagnostic Test – Product Status 63
Table 97: hENT1 Companion Diagnostic Test – Product Description 63
Table 98: Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 99: Pancreatic Cancer Diagnostic Panel – Product Status 64
Table 100: Pancreatic Cancer Diagnostic Panel – Product Description 64
Table 101: CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65
Table 102: caPCNA – Pancreatic Cancer – Product Status 65
Table 103: caPCNA – Pancreatic Cancer – Product Description 65
Table 104: Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview 66
Table 105: NanoMabKv – Pancreatic Cancer – Product Status 66
Table 106: NanoMabKv – Pancreatic Cancer – Product Description 66
Table 107: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 67
Table 108: Liquid Biopsy Test – Pancreatic Cancer – Product Status 67
Table 109: Liquid Biopsy Test – Pancreatic Cancer – Product Description 67
Table 110: Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 68
Table 111: Diagnostic Test – Pancreatic Cancer – Product Status 68
Table 112: Diagnostic Test – Pancreatic Cancer – Product Description 68
Table 113: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Table 114: Lumipulse G – NCC-ST439 Assay – Product Status 69
Table 115: Lumipulse G – NCC-ST439 Assay – Product Description 69
Table 116: GlycoZym USA Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Table 117: Diagnostic Assay – Pancreatic Cancer – Product Status 70
Table 118: Diagnostic Assay – Pancreatic Cancer – Product Description 70
Table 119: Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview 71
Table 120: Diagnostic Test – Pancreatic Cancer – Product Status 71
Table 121: Diagnostic Test – Pancreatic Cancer – Product Description 71
Table 122: Houston Methodist Hospital Pipeline Products & Ongoing Clinical Trials Overview 72
Table 123: Diagnostic Test – Pancreatic Ductal Adenocarcinoma – Product Status 72
Table 124: Diagnostic Test – Pancreatic Ductal Adenocarcinoma – Product Description 72
Table 125: ImmunoCellular Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
Table 126: Diagnostic Test – Pancreatic Cancer – Product Status 73
Table 127: Diagnostic Test – Pancreatic Cancer – Product Description 73
Table 128: Immunomedics Inc Pipeline Products & Ongoing Clinical Trials Overview 74
Table 129: Companion Diagnostic Assay – Clivatuzumab – Product Status 74
Table 130: Companion Diagnostic Assay – Clivatuzumab – Product Description 74
Table 131: Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview 75
Table 132: IMMray PanCan-m Test – Product Status 75
Table 133: IMMray PanCan-m Test – Product Description 75
Table 134: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 76
Table 135: Magnetic Bead-Based Multiplex Immunoassay – Pancreatic Cancer – Product Status 76
Table 136: Magnetic Bead-Based Multiplex Immunoassay – Pancreatic Cancer – Product Description 76
Table 137: JW Bioscience Pipeline Products & Ongoing Clinical Trials Overview 77
Table 138: Diagnostic Kit – Pancreatic Cancer – Product Status 77
Table 139: Diagnostic Kit – Pancreatic Cancer – Product Description 77
Table 140: Leitat Technological Center Pipeline Products & Ongoing Clinical Trials Overview 78
Table 141: ELISA Kit – S100A4 – Pancreatic Cancer – Product Status 78
Table 142: ELISA Kit – S100A4 – Pancreatic Cancer – Product Description 78
Table 143: ELISA Kit – S100P – Pancreatic Cancer – Product Status 79
Table 144: ELISA Kit – S100P – Pancreatic Cancer – Product Description 79
Table 145: Matrix-Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 80
Table 146: VeraMarker Pancreatic Cancer Test – Product Status 80
Table 147: VeraMarker Pancreatic Cancer Test – Product Description 80
Table 148: MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 81
Table 149: Mitomic Pancreatic Test – Product Status 81
Table 150: Mitomic Pancreatic Test – Product Description 81
Table 151: Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 82
Table 152: Diagnostic Test – Pancreatic Ductal Adenocarcinoma – Product Status 82
Table 153: Diagnostic Test – Pancreatic Ductal Adenocarcinoma – Product Description 82
Table 154: Merrimack Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 83
Table 155: MM-141 Companion Diagnostic Assay – Pancreatic Cancer – Product Status 83
Table 156: MM-141 Companion Diagnostic Assay – Pancreatic Cancer – Product Description 83
Table 157: Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 84
Table 158: Diagnostic Assay – Pancreatic Cancer – Product Status 84
Table 159: Diagnostic Assay – Pancreatic Cancer – Product Description 84
Table 160: Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview 85
Table 161: Immunoassay – Pancreatic Cancer – Product Status 85
Table 162: Immunoassay – Pancreatic Cancer – Product Description 85
Table 163: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 86
Table 164: myPath Pancreatic Cancer – Product Status 86
Table 165: myPath Pancreatic Cancer – Product Description 86
Table 166: NanoScale Corp Pipeline Products & Ongoing Clinical Trials Overview 87
Table 167: Diagnostic Test – Pancreatic Cancer – Product Status 87
Table 168: Diagnostic Test – Pancreatic Cancer – Product Description 87
Table 169: Nanoview Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Table 170: PDAC Assay – Product Status 88
Table 171: PDAC Assay – Product Description 88
Table 172: NatiMab Therapeutics Srl Pipeline Products & Ongoing Clinical Trials Overview 89
Table 173: ELISA-Based ENOA-Abs Kit – Product Status 89
Table 174: ELISA-Based ENOA-Abs Kit – Product Description 89
Table 175: ELISA-based EZR-Abs Kit – Product Status 90
Table 176: ELISA-based EZR-Abs Kit – Product Description 90
Table 177: Three Marker Panel Assay – Product Status 90
Table 178: Three Marker Panel Assay – Product Description 91
Table 179: National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 92
Table 180: Diagnostic Biomarker – Pancreatic Cancer – Product Status 92
Table 181: Diagnostic Biomarker – Pancreatic Cancer – Product Description 92
Table 182: Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview 93
Table 183: EarlyCDT – Pancreatic Cancer – Product Status 93
Table 184: EarlyCDT – Pancreatic Cancer – Product Description 93
Table 185: Oncomatryx Biopharma SL Pipeline Products & Ongoing Clinical Trials Overview 94
Table 186: ELISA-Based Companion Diagnostic Kit – MTX3 – Product Status 94
Table 187: ELISA-Based Companion Diagnostic Kit – MTX3 – Product Description 94
Table 188: Immunohistochemistry Based Companion Diagnostic Kit – MTX3 – Product Status 95
Table 189: Immunohistochemistry Based Companion Diagnostic Kit – MTX3 – Product Description 95
Table 190: Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96
Table 191: Pan Cancer Screening and Detection Test – Product Status 96
Table 192: Pan Cancer Screening and Detection Test – Product Description 96
Table 193: Pan-Cancer Metastatic Marker Test – Product Status 97
Table 194: Pan-Cancer Metastatic Marker Test – Product Description 97
Table 195: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 98
Table 196: Diagnostic Test – Pancreatic Cancer – Product Status 98
Table 197: Diagnostic Test – Pancreatic Cancer – Product Description 98
Table 198: OTraces Inc Pipeline Products & Ongoing Clinical Trials Overview 99
Table 199: Protein Based Diagnostic Test – Pancreatic Cancer – Product Status 99
Table 200: Protein Based Diagnostic Test – Pancreatic Cancer – Product Description 99
Table 201: Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 100
Table 202: Diagnostic Test – Pancreatic Cancer – Product Status 100
Table 203: Diagnostic Test – Pancreatic Cancer – Product Description 100
Table 204: Penn Medicine Pipeline Products & Ongoing Clinical Trials Overview 101
Table 205: Liquid Biopsy Test – Pancreatic Cancer – Product Status 101
Table 206: Liquid Biopsy Test – Pancreatic Cancer – Product Description 101
Table 207: Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview 102
Table 208: Saliva Test – Pancreatic Cancer – Product Status 102
Table 209: Saliva Test – Pancreatic Cancer – Product Description 102
Table 210: Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 103
Table 211: Diagnostic Assay – Pancreatic Cancer – Product Status 103
Table 212: Diagnostic Assay – Pancreatic Cancer – Product Description 103
Table 213: NEO-301 IHC Test – Product Status 104
Table 214: NEO-301 IHC Test – Product Description 104
Table 215: Preora Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 105
Table 216: Cancer Risk Stratification Test – Pancreatic Cancer – Product Status 105
Table 217: Cancer Risk Stratification Test – Pancreatic Cancer – Product Description 105
Table 218: Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 106
Table 219: Biomarker Diagnostic Test – Pancreatic Cancer – Product Status 106
Table 220: Biomarker Diagnostic Test – Pancreatic Cancer – Product Description 106
Table 221: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 107
Table 222: Diagnostic Assay – Pancreatic Cancer – Product Status 107
Table 223: Diagnostic Assay – Pancreatic Cancer – Product Description 107
Table 224: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 108
Table 225: SysQuant Global Phosphorylation Assay – Biopsy Tissue – Product Status 108
Table 226: SysQuant Global Phosphorylation Assay – Biopsy Tissue – Product Description 109
Table 227: Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 110
Table 228: Simoa HD-1 Analyzer – Pancreatic Cancer – Product Status 110
Table 229: Simoa HD-1 Analyzer – Pancreatic Cancer – Product Description 110
Table 230: Reccan Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 111
Table 231: Prognostic Test – Pancreatic Cancer – Product Status 111
Table 232: Prognostic Test – Pancreatic Cancer – Product Description 111
Table 233: Protein Based Assay – Pancreatic Cancer – Product Status 112
Table 234: Protein Based Assay – Pancreatic Cancer – Product Description 112
Table 235: RISE Life Science Corp Pipeline Products & Ongoing Clinical Trials Overview 113
Table 236: Diagnostic Test – Pancreatic Cancer – Product Status 113
Table 237: Diagnostic Test – Pancreatic Cancer – Product Description 113
Table 238: Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 114
Table 239: Blood Test – Pancreatic Cancer – Product Status 114
Table 240: Blood Test – Pancreatic Cancer – Product Description 114
Table 241: Sanguine Diagnostics and Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 115
Table 242: Muc4/16 Assay – Pancreatic Cancer – Product Status 115
Table 243: Muc4/16 Assay – Pancreatic Cancer – Product Description 115
Table 244: Seromic Mucin Signature Biomarker Test – Pancreatic Cancer – Product Status 116
Table 245: Seromic Mucin Signature Biomarker Test – Pancreatic Cancer – Product Description 116
Table 246: SDIX LLC Pipeline Products & Ongoing Clinical Trials Overview 117
Table 247: Pancreatic Cancer Assay – Product Status 117
Table 248: Pancreatic Cancer Assay – Product Description 117
Table 249: Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 118
Table 250: CL-2000i – CA242 Test – Product Status 118
Table 251: CL-2000i – CA242 Test – Product Description 119
Table 252: Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 120
Table 253: Diagnostic Test – Pancreatic Cancer – Product Status 120
Table 254: Diagnostic Test – Pancreatic Cancer – Product Description 120
Table 255: Sienna Test – Pancreatic Cancer – Product Status 121
Table 256: Sienna Test – Pancreatic Cancer – Product Description 121
Table 257: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 122
Table 258: SomaSignal Test – Pancreatic Cancer – Product Status 122
Table 259: SomaSignal Test – Pancreatic Cancer – Product Description 122
Table 260: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 123
Table 261: Biomarker Assay – Pancreatic Cyst – Product Status 123
Table 262: Biomarker Assay – Pancreatic Cyst – Product Description 123
Table 263: Taizhou ZECEN Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 124
Table 264: CA242 Detection Kit – Product Status 124
Table 265: CA242 Detection Kit – Product Description 124
Table 266: Temple University Health System Pipeline Products & Ongoing Clinical Trials Overview 125
Table 267: Diagnostic Test – Pancreatic Cancer – Product Status 125
Table 268: Diagnostic Test – Pancreatic Cancer – Product Description 125
Table 269: Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview 126
Table 270: Diagnostic Test – Pancreatic Cancer – Product Status 126
Table 271: Diagnostic Test – Pancreatic Cancer – Product Description 126
Table 272: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 127
Table 273: Liquid Biopsy Diagnostic Test – Pancreatic Cancer – Product Status 127
Table 274: Liquid Biopsy Diagnostic Test – Pancreatic Cancer – Product Description 127
Table 275: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 128
Table 276: Diagnostic Test – Pancreatic Cancer – Product Status 128
Table 277: Diagnostic Test – Pancreatic Cancer – Product Description 128
Table 278: University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 129
Table 279: Diagnostic Test – Pancreatic Cancer – Product Status 129
Table 280: Diagnostic Test – Pancreatic Cancer – Product Description 129
Table 281: Urine Test – Pancreatic Cancer – Product Status 130
Table 282: Urine Test – Pancreatic Cancer – Product Description 130
Table 283: University of Liverpool – Ongoing Clinical Trials Overview 131
Table 284: Diagnostic Test – Pancreatic Cancer – A Clinical Study of Diagnostic Test to Identify Pancreatic Cancer Earlier in Patients with New-onset Diabetes 132
Table 285: University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 133
Table 286: Biomarker Test – Pancreatic Cancer – Product Status 133
Table 287: Biomarker Test – Pancreatic Cancer – Product Description 133
Table 288: Liquid Biopsy Test – Pancreatic Cancer – Product Status 134
Table 289: Liquid Biopsy Test – Pancreatic Cancer – Product Description 134
Table 290: University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 135
Table 291: Biomarker Test – Pancreatic Cancer – Product Status 135
Table 292: Biomarker Test – Pancreatic Cancer – Product Description 135
Table 293: Protein Marker Test – Pancreatic Cancer – Product Status 136
Table 294: Protein Marker Test – Pancreatic Cancer – Product Description 136
Table 295: University of Washington Pipeline Products & Ongoing Clinical Trials Overview 137
Table 296: Diagnostic Test – Pancreatic Cancer – Product Status 137
Table 297: Diagnostic Test – Pancreatic Cancer – Product Description 137
Table 298: US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 138
Table 299: Blood-Based Biomarker – Pancreatic Cancer – Product Status 138
Table 300: Blood-Based Biomarker – Pancreatic Cancer – Product Description 138
Table 301: Vajra Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 139
Table 302: miRNA Biomarker – Pancreatic Cancer – Product Status 139
Table 303: miRNA Biomarker – Pancreatic Cancer – Product Description 139
Table 304: Vastcon Inc Pipeline Products & Ongoing Clinical Trials Overview 140
Table 305: Companion Diagnostic Assay – Pancreatic Cancer – Product Status 140
Table 306: Companion Diagnostic Assay – Pancreatic Cancer – Product Description 140
Table 307: Ventana Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 141
Table 308: PEGPH20 Companion Diagnostic Assay – Pancreatic Cancer – Product Status 141
Table 309: PEGPH20 Companion Diagnostic Assay – Pancreatic Cancer – Product Description 141
Table 310: Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
Table 311: Viomics Diagnostic Assay – Pancreatic Cancer – Product Status 142
Table 312: Viomics Diagnostic Assay – Pancreatic Cancer – Product Description 142
Table 313: VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview 143
Table 314: NuQ Diagnostic Test – Pancreatic Cancer – Product Status 143
Table 315: NuQ Diagnostic Test – Pancreatic Cancer – Product Description 143
Table 316: VolitionRX Ltd – Ongoing Clinical Trials Overview 144
Table 317: NuQ Diagnostic Test – Pancreatic Cancer – Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ Blood Test for Pancreatic Cancer 145
Table 318: ZORA Biosciences Oy Pipeline Products & Ongoing Clinical Trials Overview 146
Table 319: Lipidomic Marker Test – Pancreatic Cancer – Product Status 146
Table 320: Lipidomic Marker Test – Pancreatic Cancer – Product Description 146